tiprankstipranks
Immunic (IMUX)
NASDAQ:IMUX

Immunic Stock Analysis & Ratings

IMUX Stock Chart & Stats

Day’s Range$5.96 - $6.72
52-Week Range$4.96 - $15.12
Previous Close$6.05
Volume271.72K
Average Volume (3M)259.45K
Market Cap$198.82M
P/E Ratio-1.6
Beta1.87
Next EarningsAug 10, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
Smart Score3
EPS (TTM)-4.02


Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

IMUX FAQ

What was Immunic’s price range in the past 12 months?
Immunic lowest stock price was $4.96 and its highest was $15.12 in the past 12 months.
    What is Immunic’s market cap?
    Immunic’s market cap is $198.82M.
      What is Immunic’s price target?
      The average price target for Immunic is $48.33. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $61.00 ,the lowest forecast is $39.00. The average price target represents 642.40% Increase from the current price of $6.51.
        What do analysts say about Immunic?
        Immunic’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 3 Wall Streets Analysts.
          When is Immunic’s upcoming earnings report date?
          Immunic’s upcoming earnings report date is Aug 10, 2022 which is in 84 days.
            How were Immunic’s earnings last quarter?
            Immunic released its earnings results on May 10, 2022. The company reported -$0.74 earnings per share for the quarter, beating the consensus estimate of -$0.809 by $0.069.
              Is Immunic overvalued?
              According to Wall Street analysts Immunic’s price is currently Undervalued.
                Does Immunic pay dividends?
                Immunic does not currently pay dividends.
                What is Immunic’s EPS estimate?
                Immunic’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does Immunic have?
                Immunic has 30,540,000 shares outstanding.
                  What happened to Immunic’s price movement after its last earnings report?
                  Immunic reported an EPS of -$0.74 in its last earnings report, beating expectations of -$0.809. Following the earnings report the stock price went up 5.364%.
                    Which hedge fund is a major shareholder of Immunic?
                    Among the largest hedge funds holding Immunic’s share is Omega Fund Management, LLC. It holds Immunic’s shares valued at 20M.

                      ---

                      Immunic Stock Analysis

                      Smart Score
                      3
                      Underperform
                      1
                      2
                      3
                      4
                      5
                      6
                      7
                      8
                      9
                      10
                      Price Target
                      $48.33
                      ▲(642.40% Upside)
                      Strong Buy
                      The Immunic stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                      Learn more about TipRanks Smart Score

                      Company Description

                      Immunic

                      Immunic, Inc. engages in developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. Its products include IMU-838, IMU-935, and IMU-856. The company is headquartered in San Diego, CA.

                      ---
                      Similar Stocks
                      Company
                      Price & Change
                      Follow
                      Baxter International
                      Chembio Diagnostics
                      Gilead Sciences
                      MyMD Pharmaceuticals
                      Orasure Technologies

                      Popular Stocks

                      ---
                      What's Included in PREMIUM?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis